|
1
|
American Cancer Society (ACS): Cancer
Facts and Figures 2009. ACS. Atlanta: 2009.
|
|
2
|
Lucca I, de Martino M, Klatte T and
Shariat SF: Novel biomarkers to predict response and prognosis in
localized bladder cancer. Urol Clin North Am. 42:225–233. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vakkila J and Lotze MT: Inflammation and
necrosis promote tumor growth. Nat Rev Immunol. 4:641–648. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Scott HR, McMillan DC, Forrest LM, Brown
DJ, McArdle CS and Milroy R: The systemic inflammatory response,
weight loss, performance status and survival in patients with
inoperable non-small cell lung cancer. Br J Cancer. 87:264–267.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moore MM, Chua W, Charles KA and Clarke
SJ: Inflammation and cancer: Causes and consequences. Clin Pharmacol
Ther. 87:504–508. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nielsen HJ, Hansen U, Christensen IJ,
Reimert CM, Brünner N and Moesgaard F: Independent prognostic value
of eosinophil and mast cell infiltration in colorectal cancer
tissue. J Pathol. 189:487–495. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nakano O, Sato M, Naito Y, Suzuki K,
Orikasa S, Aizawa M, Suzuki Y, Shintaku I, Nagura H and Ohtani H:
Proliferative activity of intratumoral CD8+
T-lymphocytes as a prognostic factor in human renal cell carcinoma:
Clinicopathologic demonstration of antitumor immunity. Cancer Res.
61:5132–5136. 2001.PubMed/NCBI
|
|
9
|
Hilmy M, Campbell R, Bartlett JM, McNicol
AM, Underwood MA and McMillan DC: The relationship between the
systemic inflammatory response, tumor proliferative activity,
T-lymphocytic infiltration and COX-2 expression and survival in
patients with transitional cell carcinoma of the urinary bladder.
Br J Cancer. 95:1234–1238. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roxburgh CS, Salmond JM, Horgan PG, Oien
KA and McMillan DC: Comparison of the prognostic value of
inflammation-based pathologic and biochemical criteria in patients
undergoing potentially curative resection for colorectal cancer.
Ann Surg. 249:788–793. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Crumley AB, McMillan DC, McKernan M,
McDonald AC and Stuart RC: Evaluation of an inflammation-based
prognostic score in patients with inoperable gastro-oesophageal
cancer. Br J Cancer. 94:637–641. 2006.PubMed/NCBI
|
|
12
|
Lamb GW, McArdle PA, Ramsey S, McNichol
AM, Edwards J, Aitchison M and McMillan DC: The relationship
between the local and systemic inflammatory responses and survival
in patients undergoing resection for localized renal cancer. BJU
Int. 102:756–761. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McArdle PA, Qayyum T and McMillan DC:
Systemic inflammatory response and survival in patients with
localized prostate cancer: 10-year follow-up. Urol Int. 84:430–435.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Saito K and Kihara K: Role of C-reactive
protein in urological cancers: A useful biomarker for predicting
outcomes. Int J Urol. 20:161–171. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
McMillan DC: The systemic
inflammation-based Glasgow prognostic score: A decade of experience
in patients with cancer. Cancer Treat Rev. 39:534–540. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gakis G, Todenhöfer T, Renninger M,
Schilling D, Sievert KD, Schwentner C and Stenzl A: Development of
a new outcome prediction model in carcinoma invading the bladder
based on preoperative serum C-reactive protein and standard
pathological risk factors: The TNR-C score. BJU Int. 108:1800–1805.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
McMillan DC: Systemic inflammation,
nutritional status and survival in patients with cancer. Curr Opin
Clin Nutr Metab Care. 12:223–226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Heys SD, Walker LG, Deehan DJ and Eremin
OE: Serum albumin: a prognostic indicator in patients with
colorectal cancer. J R Coll Surg Edinb. 43:163–168. 1998.PubMed/NCBI
|
|
19
|
Ku JH, Kim M, Choi WS, Kwak C and Kim HH:
Preoperative serum albumin as a prognostic factor in patients with
upper urinary tract urothelial carcinoma. Int Braz J Urol.
40:753–762. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gregg JR, Cookson MS, Phillips S, Salem S,
Chang SS, Clark PE, Davis R, Stimson CJ Jr, Aghazadeh M, Smith JA
Jr and Barocas DA: Effect of preoperative nutritional deficiency on
mortality after radical cystectomy for bladder cancer. J Urol.
185:90–96. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cho YK, Chung JW, Kim JK, Ahn YS, Kim MY,
Park YO, Kim WT and Byun JH: Comparison of 7 staging systems for
patients with hepatocellular carcinoma undergoing transarterial
chemoembolization. Cancer. 112:352–361. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McMillan DC: An inflammation-based
prognostic score and its role in the nutrition-based management of
patients with cancer. Proc Nutr Soc. 67:257–262. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Proctor MJ, Morrison DS, Talwar D, Balmer
SM, Fletcher CD, O'Reilly DS, Foulis AK, Horgan PG and McMillan DC:
A comparison of inflammation-based prognostic scores in patients
with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer.
47:2633–2641. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Al Murri AM, Doughty JC, Lannigan A,
Wilson C, McArdle CS and McMillan DC: The relationship between
deprivation, tumor stage and the systemic inflammatory response in
patients with primary operable breast cancer. Br J Cancer.
91:1063–1065. 2004.PubMed/NCBI
|
|
25
|
Pollheimer MJ, Kornprat P, Lindtner RA,
Harbaum L, Schlemmer A, Rehak P and Langner C: Tumor necrosis is a
new promising prognostic factor in colorectal cancer. Hum Pathol.
41:1749–1757. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sengupta S, Lohse CM, Leibovich BC, Frank
I, Thompson RH, Webster WS, Zincke H, Blute ML, Cheville JC and
Kwon ED: Histologic coagulative tumor necrosis as a prognostic
indicator of renal cell carcinoma aggressiveness. Cancer.
104:511–520. 2005. View Article : Google Scholar : PubMed/NCBI
|
